COVID-19 disproportionately affects the finances of low-income workers in developing countries

2-Oct-2020 1:35 PM EDT, by PLOS

Newswise — Results from a large-scale survey of households in Latin America and the Caribbean show that the negative economic impacts of the COVID-19 pandemic have been concentrated among those who had lower incomes prior to the pandemic, according to a study published October 7 in the open-access journal PLOS ONE by Nicolas Bottan of Cornell University, Bridget Hoffmann and Diego Vera-Cossio of the Inter-American Development Bank. 

The current coronavirus pandemic is an unprecedented public health challenge that is having a devastating economic impact on households. To slow the spread of COVID-19, governments have implemented regulations that require social distancing, the closing of non-essential businesses, travel restrictions and, in many cases, stay-at-home orders. Although these measures may be necessary for public health, they have negative economic​impacts and can potentially deepen the pre-existing gaps between rich and poor. Prior to the pandemic, Latin America and the Caribbean in particular had the highest income inequality in the world, and many citizens were vulnerable to falling back into poverty due to economic shocks. In the new study, Bottan and his collaborators used an online survey with 230,540 respondents from 17 countries in Latin America and the Caribbean to examine whether the COVID-19 pandemic has resulted in differential economic impacts for households across the income distribution. 

The data revealed large job losses and business closures which most affected the lowest income households. Of households reporting income of less than the national monthly minimum wage for January 2020, 71 percent reported that a household member lost their job and 61 percent reported that a household member closed their business. These findings contrast sharply with the impacts reported by the highest income respondents, just 14 percent of whom reported that a household member lost their job and 54 percent of whom reported that a household member closed their business. Their data suggest that job losses and business closures lead to reductions in health and food security, further contributing to the disproportionate impacts across income levels. 

According to the authors, the findings provide evidence that the current public health crisis will exacerbate economic inequality, and also provide some of the first estimates of the impact of the pandemic on the labor market and on well-being in developing countries. 

The authors add: “Using online surveys from seventeen countries in Latin America and the Caribbean we document that the covid-19 pandemic has large, unequal effects on job loss and business closure. The loss of livelihood leads to reductions in health and nutrition, further exacerbating economic inequality in the region.”

 

#####

 

Funding: This project was funded by the Inter-American Development Bank’s Coronavirus research funds (RG-E1700 - Coronavirus survey). The funder provided support in the form of salaries for authors Bridget Hoffmann and Diego Vera-Cossio, and provided funds to cover the cost of recruiting subjects via social media advertising, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

 

Competing Interests: The authors Bridget Hoffmann and Diego A. Vera-Cossio are employees in the Research Department at the Inter-American Development Bank. The author Nicolas Bottan is employed at Cornell University. The authors have no relevant financial or non-financial competing interests to declare. Our affiliations do not alter our adherence to PLOS ONE policies on sharing data and materials.

 

In your coverage please use this URL to provide access to the freely available article in PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239797

 

 

About PLOS ONE

PLOS ONE is a multidisciplinary, peer-reviewed open access journal that publishes sound science from all fields of scientific research.  For more information, visit http://journals.plos.org/plosone, and follow @PLOSONE on Twitter.

 

Media and Copyright Information

For information about PLOS ONE relevant to journalists, bloggers and press officers, including details of our press release process and embargo policy, visit http://journals.plos.org/plosone/s/press-and-media.

 

PLOS Journals publish under a Creative Commons Attribution License, which permits free reuse of all materials published with the article, so long as the work is cited. 

 

About the Public Library of Science
Public Library of Science (PLOS) is a nonprofit Open Access publisher, innovator and advocacy organization dedicated to accelerating progress in science and medicine by leading a transformation in research communication. The PLOS suite of journals contain rigorously peer-reviewed Open Access research articles from all areas of science and medicine, together with expert commentary and analysis. In addition to journals, the organization advances innovations in scientific publishing through Collections, Communities and The PLOS Blog Network. Founded to catalyze a revolution in scientific publishing by demonstrating the value and feasibility of Open Access publication, PLOS is committed to innovative and forward-looking solutions to scientific communication. For more information, visit http://www.plos.org.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.08541